---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-067798"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2025-07-25T23:59:59+00:00"
generated_at: "2026-05-18T01:16:54.976109+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OSR Holdings enters term sheet to acquire Woori IO for noninvasive glucose monitoring tech

## Summary
- Non-binding term sheet: OSRK to acquire WORIO via share exchange; WORIO shareholders receive OSRK shares convertible into OSRH common stock.
- Conversion conditional on OSRH stock reaching $10.00 within 3 years; fixed ratio 1 OSRK = 12.96 OSRH shares.
- 6-month exclusivity period for due diligence; parties aim to complete transaction within that period.
- WORIO's platform uses near-infrared spectroscopy (NIRS) for noninvasive glucose monitoring; completed proof-of-concept with Korea University Hospital.
- Glucose monitoring devices market projected to exceed $40B by 2030; WORIO selected by Samsung C-Lab Outside in Q1 2025.

## SEC filing metadata
- accession: 0001213900-25-067798
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2025-07-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000121390025067798/0001213900-25-067798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000121390025067798/ea0250305-8k_osrhold.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-067798
- JSON: https://secwatch.observer/filing/0001213900-25-067798.json
- Plain text: https://secwatch.observer/filing/0001213900-25-067798.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.